These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30833106)

  • 1. Microvascular complications in diabetes: A growing concern for cardiologists.
    Avogaro A; Fadini GP
    Int J Cardiol; 2019 Sep; 291():29-35. PubMed ID: 30833106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and diabetic complications: focus on the vasculature.
    Ergul A
    Pharmacol Res; 2011 Jun; 63(6):477-82. PubMed ID: 21292003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves.
    Mauricio D; Gratacòs M; Franch-Nadal J
    Cardiovasc Diabetol; 2023 Nov; 22(1):314. PubMed ID: 37968679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Asymmetrical Dimethylarginine in Diabetic Microvascular Complications.
    Du MR; Ju GX; Li NS; Jiang JL
    J Cardiovasc Pharmacol; 2016 Oct; 68(4):322-326. PubMed ID: 27760067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of diabetic control to development of microvascular complications.
    Tchobroutsky G
    Diabetologia; 1978 Sep; 15(3):143-52. PubMed ID: 359393
    [No Abstract]   [Full Text] [Related]  

  • 7. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
    Rodbard HW; Blonde L; Braithwaite SS; Brett EM; Cobin RH; Handelsman Y; Hellman R; Jellinger PS; Jovanovic LG; Levy P; Mechanick JI; Zangeneh F;
    Endocr Pract; 2007; 13 Suppl 1():1-68. PubMed ID: 17613449
    [No Abstract]   [Full Text] [Related]  

  • 8. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?
    Bell DS; O'Keefe JH; Jellinger P
    Endocr Pract; 2008; 14(1):112-24. PubMed ID: 18238751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF
    Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose variability, HbA1c and microvascular complications.
    Škrha J; Šoupal J; Škrha J; Prázný M
    Rev Endocr Metab Disord; 2016 Mar; 17(1):103-10. PubMed ID: 26975588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from vascular risk in diabetic hypertension.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 2000 Apr; 2(2):154-9. PubMed ID: 10981142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and Diagnosis of Diabetes Mellitus and Its Complication: Advanced Approaches.
    Sen S; Chakraborty R
    Mini Rev Med Chem; 2015; 15(14):1132-3. PubMed ID: 26459815
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update diabetes mellitus and cardiovascular diseases].
    Otter W
    MMW Fortschr Med; 2012 Apr; 154(7):95-8. PubMed ID: 22558884
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
    Yamagishi S; Imaizumi T
    Curr Pharm Des; 2005; 11(18):2279-99. PubMed ID: 16022668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of diabetes mellitus and its complications. 7. Control of blood glucose and diabetic microangiopathy].
    Shichiri M
    Nihon Naika Gakkai Zasshi; 1996 Sep; 85(9):1484-9. PubMed ID: 8999095
    [No Abstract]   [Full Text] [Related]  

  • 16. Foreword.
    Aminoff MJ; Boller F; Swaab DF
    Handb Clin Neurol; 2014; 126():vii. PubMed ID: 25410247
    [No Abstract]   [Full Text] [Related]  

  • 17. (9) Microvascular complications and foot care.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S58-66. PubMed ID: 25537710
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?
    Yamagishi S; Matsui T
    Pharmacol Res; 2011 Sep; 64(3):187-94. PubMed ID: 21635951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry and molecular cell biology of diabetic complications.
    Brownlee M
    Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic macroangiopathy--therapy and prevention].
    Oikawa S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():146-50. PubMed ID: 12386986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.